本帖最后由 橙色雨丝 于 2017-10-31 14:05 编辑
Hodgkin disease (1973–2002): long-term survival and cure fractionsGeorge Bouliotis Medical Research Council Midlands Hub for Trials Methodology Research, University of Birmingham, Birmingham, UK & Eric M. Bessell Department of Clinical Oncology, Nottingham City Hospital, Nottingham, UKCorrespondenceebessell@hotmail.co.uk
The Nottinghamshire Lymphoma Registry contains the details of all patients diagnosed with lymphoma (since 1 January 1973) within a defined geographical area with a stable population of 1.1 million. The aim of this study was to investigate the relative survival and estimate the cure fraction for patients with Hodgkin disease (HD) using various cure fraction models. Five- and 10-year survival was estimated in comparison to the general population of the same age, gender and year of diagnosis. Relative survival probabilities at 10 years were 52.3% for the 1973–1982 cohort, 67.8% (1983–1992) and 75.7% (1993–2002). The estimated cured fraction (π) was 45%, 65% and 75%, respectively, for the same cohorts. There was very little excess mortality after 4 years from treatment. The prognosis of patients with HD has improved progressively within a defined unselected population over this 30-year period. In the 1993–2002 cohort the prognosis after 4 years of treatment is almost the same as for a normal population.
早些年间霍奇金治疗毒性较大,特别是放疗技术不好,所以远期副作用大,影响总生存率。不过,现在无论是化疗还是放疗技术都有了长足的进步,远期风险已经很小,比如说根据英国的一项研究,1993年-2002年期间治疗的霍奇金患者,如果四年内没有复发,其预期寿命基本与正常人群相当。
|